Fintel reports that on July 11, 2023, Barclays maintained coverage of Chemours (NYSE:CC) with a Equal-Weight recommendation.
Analyst Price Forecast Suggests 4.93% Upside
As of July 6, 2023, the average one-year price target for Chemours is 39.07. The forecasts range from a low of 25.25 to a high of $67.20. The average price target represents an increase of 4.93% from its latest reported closing price of 37.23.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Chemours is 6,784MM, an increase of 3.32%. The projected annual non-GAAP EPS is 4.55.
Chemours Declares $0.25 Dividend
On April 27, 2023 the company declared a regular quarterly dividend of $0.25 per share ($1.00 annualized). Shareholders of record as of May 15, 2023 received the payment on June 15, 2023. Previously, the company paid $0.25 per share.
At the current share price of $37.23 / share, the stock's dividend yield is 2.69%.
Looking back five years and taking a sample every week, the average dividend yield has been 4.11%, the lowest has been 1.50%, and the highest has been 12.18%. The standard deviation of yields is 1.85 (n=235).
The current dividend yield is 0.77 standard deviations below the historical average.
Additionally, the company's dividend payout ratio is 0.31. The payout ratio tells us how much of a company's income is paid out in dividends. A payout ratio of one (1.0) means 100% of the company's income is paid in a dividend. A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Companies with few growth prospects are expected to pay out most of their income in dividends, which typically means a payout ratio between 0.5 and 1.0. Companies with good growth prospects are expected to retain some earnings in order to invest in those growth prospects, which translates to a payout ratio of zero to 0.5.
The company has not increased its dividend in the last three years.
What is the Fund Sentiment?
There are 937 funds or institutions reporting positions in Chemours. This is a decrease of 9 owner(s) or 0.95% in the last quarter. Average portfolio weight of all funds dedicated to CC is 0.17%, an increase of 4.27%. Total shares owned by institutions decreased in the last three months by 1.90% to 119,537K shares. 
The put/call ratio of CC is 0.88, indicating a bullish outlook.
What are Other Shareholders Doing?
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 4,592K shares representing 3.08% ownership of the company. In it's prior filing, the firm reported owning 4,597K shares, representing a decrease of 0.12%. The firm decreased its portfolio allocation in CC by 9.82% over the last quarter.
IJH - iShares Core S&P Mid-Cap ETF holds 4,576K shares representing 3.07% ownership of the company. In it's prior filing, the firm reported owning 4,661K shares, representing a decrease of 1.84%. The firm decreased its portfolio allocation in CC by 8.11% over the last quarter.
NAESX - Vanguard Small-Cap Index Fund Investor Shares holds 3,882K shares representing 2.60% ownership of the company. In it's prior filing, the firm reported owning 3,888K shares, representing a decrease of 0.15%. The firm decreased its portfolio allocation in CC by 6.29% over the last quarter.
DVY - iShares Select Dividend ETF holds 3,830K shares representing 2.57% ownership of the company. In it's prior filing, the firm reported owning 4,491K shares, representing a decrease of 17.26%. The firm decreased its portfolio allocation in CC by 24.62% over the last quarter.
Jpmorgan Chase holds 3,164K shares representing 2.12% ownership of the company. In it's prior filing, the firm reported owning 2,885K shares, representing an increase of 8.83%. The firm decreased its portfolio allocation in CC by 0.89% over the last quarter.
Chemours Background Information
(This description is provided by the company.)
The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining, and general industrial manufacturing. Its flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™. In 2019, Chemours was named to Newsweek's list of America's Most Responsible Companies. The company has approximately 7,000 employees and 30 manufacturing sites serving approximately 3,700 customers in over 120 countries. Chemours is headquartered in Wilmington, Delaware.
Additional reading:
- UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION
- UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION
- Examples of Determining PFAS Score:
- Aqueous Film-Forming Foam (AFFF) Products Liability Litigation (MDL 2873) Public Water System Settlement Claims Form
- UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
